Best Peptide Company in 2026: 6 Vendors Ranked by Verifiable Transparency

Peptide Sciences shut down March 6, 2026. It processed $7.4M per month. Amino Asylum got raided by the FDA in June 2025. The two biggest names in the space weren't the most transparent. They were the most visible.

Every best peptide company list you'll find ranks vendors by reputation, Reddit sentiment, or affiliate payouts. None publish their scoring criteria. We grade on 5 verifiable signals. Our methodology is public. This article ranks the 6 best peptide companies that earned a Grade A in our Vendor Transparency Score system, plus honorable mentions from the B tier.

The peptide therapeutics market exceeds $50B in annual sales and the Associated Press calls peptides “a trendy new approach to building muscle, smoothing wrinkles and trying to live longer.” GLP-1 demand jumped 340% following the FDA shortage resolution. Independent analysis shows approximately 73% of peptide samples from various suppliers fall below claimed purity, with 41% showing discrepancies exceeding 10 percentage points.

Three forces converged in late 2025: FDA enforcement acceleration, Eli Lilly and Novo Nordisk patent lawsuits against grey-market GLP-1 suppliers, and independent testing exposing quality gaps. In February 2026, RFK Jr. announced roughly 14 previously restricted peptides would return to Category 1 for licensed compounding. Supply is expanding. Mainstream attention is spiking. The top peptide companies willing to show receipts are the ones worth your attention.

1. How We Ranked These Peptide Companies

We score vendors on a 5-signal model. Three signals are core evidence. Two are supporting trust indicators. Every signal is independently verifiable before you place an order.

Core Evidence (the receipts):

• Public COA Access. Does the vendor post Certificates of Analysis on a dedicated page, or do you have to email and ask? Publicly posted = 1.0. Behind a request form = 0.5. No COAs anywhere = 0.
• Batch Traceability. Do the COAs include batch or lot numbers that match what ships? Visible batch IDs on COAs and vial labels = 1.0. Partial = 0.5. No batch info = 0.
• Named, Verifiable Testing Lab. Is the lab name on the COA? Can you Google it and confirm it exists as an independent testing facility? Named and findable = 1.0. Named but unverifiable = 0.5. No lab named = 0.

Supporting Trust:

• Dedicated Policy Pages. Do standalone refund and shipping policy URLs exist? Both = 1.0. One or combined in FAQ = 0.5. None = 0.
• Identifiable Ownership. Named founders, registered business entity, or physical address. Clearly identified = 1.0. Partial (just a business name) = 0.5. Fully anonymous = 0.

Each signal scores 0, 0.5, or 1.0. Total range is 0 to 5.

Grade thresholds: A = 4.0–5.0 with at least 2 core signals, OR all 3 core signals regardless of total score. B = 3.0–3.5. C = 2.0–2.5. D = 0.5–1.5. E = 0 or disqualified.

Negative overrides sit outside the additive score. Fabricated COAs or fake lab claims trigger an automatic E. Verifiably false claims (like a fake establishment year) result in a 1-grade deduction. One vendor in our database, Paramount Peptides, caught a deduction for claiming 12+ years in business when domain and business registration records contradicted that timeline.

We don't score shipping speed, customer service responsiveness, or product purity, because those require purchasing and testing. Our system tells you which vendors are willing to be transparent. No vendor in the grey-market research peptide space has ISO 17025 accredited lab testing, so we don't penalize for it. Full details: How We Rank Vendors and How We Verify COAs.

2. NuScience Peptides: Highest Overall Transparency Score (4.5/5, Grade A)

NuScience Peptides ties for the highest Vendor Transparency Score we've recorded. They hit all three core signals plus identifiable ownership, a combination only one other vendor matches.

Signal breakdown:

Freedom Diagnostics runs their third-party testing. Each COA includes LOT numbers and accession numbers, so you can cross-reference the document with the specific batch that ships. This is batch-level accountability, not a single generic COA recycled across the catalog. Every batch gets tested before it becomes available for sale.

The external verification backs this up. Finnrick Analytics, a third-party testing aggregator, has conducted 47 independent lab tests on NuScience across 10 products as of February 2026. That's one of the largest independent verification datasets for any single US grey-market vendor. When a vendor's self-reported testing claims align with an independent third-party tracker, the confidence signal compounds.

The ownership transparency separates NuScience from most of the field. Named owners tied to a verifiable entity. In a market where anonymous LLC filings are the norm and most vendors hide behind privacy-shielded registrations, putting named individuals on record creates accountability that goes beyond product documentation. You know who stands behind the product.

NuScience shows no enforcement actions, no domain changes, and stable operations. The best peptide company in any market is the one that stays open and keeps documenting. Their catalog covers all Tier 1 research peptides with multiple dosage options.

Pricing snapshot: BPC-157 starts at $34.99/5mg. CJC-1295/Ipamorelin blend at $74.99. Tirzepatide 10mg at $89.99. Semaglutide 5mg at $79.99. Not the cheapest on any single product, but consistently mid-range with full documentation behind every vial.

Full profile: NuScience Peptides vendor page

3. Ion Peptides: Matching the Top Score With Lab Verification (4.5/5, Grade A)

Ion Peptides ties NuScience at 4.5/5. They take a different path to get there, scoring full marks on policies where NuScience scores partial, and partial on ownership where NuScience scores full.

Signal breakdown:

Both Ion and NuScience use Freedom Diagnostics for third-party testing. That lab is independently verifiable. You can confirm it exists, confirm it operates as a testing facility, and confirm the COA format matches what the lab produces.

Two vendors using the same third-party lab is useful for comparison. If Freedom Diagnostics produces COAs for both NuScience and Ion, you can compare report formats, verify the lab's output is consistent, and confirm neither vendor is fabricating documents. Two independent data points from the same source strengthen confidence in both.

Ion's policy documentation stands out. Full dedicated refund and shipping policy pages earn a 1.0, a score only two other A-tier vendors achieve. For researchers evaluating the best peptide company for a first order, published policies reduce risk before you spend money.

Ion's domain is younger than most vendors in the A tier. We flag that as a monitoring factor, not a penalty. Domain age doesn't change whether COAs are real, batch numbers match, or the testing lab exists. Every signal we've verified confirms. We'll continue watching for consistency over time, but the current evidence is clean.

The combination of all three core signals, full policy pages, and competitive pricing makes Ion a strong option for researchers placing a first order with a new vendor. Published policies mean you know the terms before you commit.

Pricing snapshot: BPC-157 at $29.00/5mg is among the lowest in the A tier. CJC-1295/Ipamorelin blend at $55.00. Tirzepatide 5mg at $49.00. Semaglutide 5mg at $49.00. Across most Tier 1 peptides, Ion runs 15–25% below NuScience while using the same testing infrastructure.

Full profile: Ion Peptides vendor page

4. Simple Peptides: Ownership Transparency Sets It Apart (4.0/5, Grade A)

Most peptide companies hide behind anonymous LLCs. Simple Peptides is owned by Melex Technologies Inc., and they don't hide it. That corporate transparency, combined with two core evidence signals, earns a 4.0.

Signal breakdown:

ScamAdviser gives Simple a 100/100 trust score. Products arrive as advertised. Support is responsive. The 74K monthly search volume on their brand name makes them one of the higher-volume vendors still operating.

The named-lab gap keeps Simple at 4.0 instead of 4.5+. Their COAs exist, batch numbers match, but the testing lab isn't identified on the documentation. That single missing signal separates them from the top tier. If Simple added a named, verifiable lab to their COAs, they'd jump to 5.0, the highest possible score.

Simple also runs a sister brand: Alpha Omega Peptides, also owned by Melex Technologies. Alpha Omega scores 3.5 (Grade B) with a different signal profile. We score each brand independently even when they share a parent company.

Their catalog uses coded GLP-1 product names. GLP-1SG is semaglutide. GLP-2TZ is tirzepatide. GLP-3RT is retatrutide. The coded naming convention is common among vendors navigating regulatory scrutiny around weight-loss peptides. Search their site by the code, not the compound name.

The r/Peptides community gives Simple generally positive sentiment, and when both verifiable signals and unstructured feedback align, that's a reasonable confidence indicator. Community data is anecdotal and doesn't factor into our scores.

Pricing snapshot: BPC-157 10mg at $55.00. CJC-1295/Ipamorelin blend at $65.00. Tirzepatide 5mg at $45.00 (coded as GLP-2TZ). Semaglutide 3mg at $38.00 (GLP-1SG). Simple runs periodic sales on GLP products, sometimes around 30% off.

Full profile: Simple Peptides vendor page | Simple Peptides review

5. Verified Peptides: All Three Core Signals Confirmed (4.0/5, Grade A)

Simple Peptides shows ownership but not the lab. Verified Peptides shows the lab but not ownership. Same grade, different transparency profiles.

Signal breakdown:

300+ public lab reports. Verified Peptides publishes a volume of third-party documentation that most vendors in any tier can't match. Each report is tied to a named testing lab you can independently confirm. Their 310 Trustpilot reviews at 5 stars corroborate the practice, with reviewers specifically citing batch-matched lab reports.

They hit all three core signals (COA, batch, lab) plus full policy pages. The only gap is ownership. No named founders, no registered business entity on public record. That zero on ownership lands them at 4.0 instead of 4.5 or higher. If you prioritize core evidence over knowing who runs the company, Verified delivers more lab documentation than any other vendor in our database.

The contrast with Simple Peptides is instructive. Two vendors, same grade, completely different approaches. Simple bets on corporate identity. Verified bets on volume of lab evidence. Both strategies produce a Grade A. Choose based on which transparency dimension matters more to your evaluation.

Pricing snapshot: BPC-157 10mg at $53.00. Tirzepatide 15mg at $69.99. Semaglutide 5mg at $49.99. Verified carries fewer dosage options per peptide than some competitors (11 products across Tier 1), but pricing is competitive with the rest of the A tier.

Full profile: Verified Peptides vendor page

6. Peptide Crafters: Core Evidence Trifecta on a Lower Score (3.5/5, Grade A)

Peptide Crafters scores 3.5 total but still earns Grade A. All three core evidence signals confirmed. Our grading system gives an A to any vendor with all three core signals regardless of total score, because those signals let you independently verify claims before you buy.

Signal breakdown:

MZ Biolabs is a DEA-licensed testing facility, a higher bar than most named labs in this space. Peptide Crafters' COAs include a 4-test panel covering more analytical ground than the typical HPLC-only report. Where many vendors stop at purity percentage, a 4-test panel adds identity confirmation and additional quality markers.

Partial policy documentation and no identifiable ownership are the gaps. Those signals measure business transparency, not product transparency. The core evidence, the part that tells you whether the peptide in the vial matches the label, is fully intact.

Pricing snapshot: BPC-157 10mg at $55.00. CJC-1295/Ipamorelin 12mg blend at $45.00. Epithalon 10mg at $30.00 (lowest in the A tier). PT-141 10mg at $30.00. Competitive pricing, particularly on specialty peptides.

Full profile: Peptide Crafters vendor page | Peptide Crafters review

7. Skye Peptides: The Minimum Viable Grade A (3.0/5, Grade A)

Skye Peptides holds the lowest total score in the A tier at 3.0. They make the cut because all three core evidence signals check out. Zero on both supporting trust signals. Pure product transparency, no corporate transparency.

Signal breakdown:

Janoshik Analytical is one of the most commonly cited third-party labs in the research peptide space. Skye takes verification further by including a QR code on physical product cards that links directly to the corresponding COA and batch number. Scan it, see the report, match it to what you received.

No refund policy page. No shipping policy page. No named founders. No business entity on record. Skye puts everything into product documentation and nothing into corporate transparency. That's a valid path to Grade A under our system, but it means you have no published policy to reference and no named individual to escalate to if an order goes wrong.

Pricing snapshot: BPC-157 5mg at $49.00, 10mg at $59.00, 25mg at $89.00. CJC-1295/Ipamorelin 10mg at $40.00. One of the broader catalogs in the A tier, with multiple dosage options per peptide including larger sizes (GHK-Cu up to 100mg, tesamorelin at 24mg).

Full profile: Skye Peptides vendor page | Skye Peptides review

8. Honorable Mentions: Grade B Vendors Worth Watching

Six vendors scored in the B range (3.0–3.5). They show meaningful transparency signals but fall short of an A for specific, documented reasons.

Alpha Omega Peptides (3.5, Grade B). Sister brand to Simple Peptides, both owned by Melex Technologies Inc. Partial COA access (0.5) keeps them below A despite a named lab. If you're considering Alpha Omega, check Simple Peptides first. Same parent company, higher transparency score.

Eternal Peptides (3.5, Grade B). Scores across all five signals but only hits partial marks on COA access, lab verification, and ownership. Broad coverage, no standout weakness, no standout strength. A solid middle-of-the-road option.

Strate Labs (3.5, Grade B). Would score higher on raw signals, but an editorial cap is applied. Strate Labs has a history of domain hopping following an ITC cease-and-desist. The transparency signals exist. The operational history raises questions the signals alone don't capture.

Biolongevity Labs (3.5, Grade B). Strong on policies and ownership (both 1.0), but only partial on COA access and zero on batch traceability. Corporate transparency is covered. Product documentation needs work.

Limitless Biotech (3.0, Grade B). Partial COA access, good batch traceability, strong policies. No named testing lab. Carries 9 of 15 Tier 1 peptides. Notable gap: no GLP-1 products (tirzepatide, semaglutide, retatrutide).

Nexaph (3.0, Grade B). All three core signals confirmed (COA 1.0, Batch 1.0, Lab 1.0), which would normally qualify for Grade A. Editorial cap applied due to fully anonymous ownership and trust gaps flagged during review. The signals say A. The editorial judgment says hold.

Each of these vendors has real transparency infrastructure, but something specific prevents the A grade. Sometimes it's a missing core signal. Sometimes it's an editorial override based on documented business history. Any of them could move to A with identifiable improvements.

All 23 active vendor profiles with full signal breakdowns: Browse all vendors

Frequently Asked Questions

What is the best peptide company right now?

Based on our 5-signal Vendor Transparency Score, NuScience Peptides and Ion Peptides tie at 4.5/5 (Grade A). Both use Freedom Diagnostics for third-party testing, both post public batch-matched COAs, and both score on ownership or policies where most competitors score zero.

Is Peptide Sciences still open?

No. Peptide Sciences voluntarily shut down on March 6, 2026. They processed approximately $7.4M per month. Refunds for pending orders and store credit have not been confirmed. We maintain an archived profile with documented alternatives.

What happened to Amino Asylum?

The FDA raided Amino Asylum's warehouse in June 2025. Payment processing was terminated. Pending orders were frozen. The site remains offline as of March 2026. We classify Amino Asylum as Archived, not graded on the active A–E scale.

Are peptide companies legal?

Research peptides are sold as “not for human consumption” research chemicals, occupying a legal grey area. FDA enforcement in 2024–2025 targeted vendors selling GLP-1 peptides (semaglutide, tirzepatide) as unapproved drugs. BPC-157 was placed on the FDA Category 2 list in September 2023. In February 2026, RFK Jr. announced approximately 14 previously restricted peptides would return to Category 1, restoring access through licensed compounding pharmacies with a prescription.

How do I verify a peptide COA?

Three steps. First, find the COA on the vendor's website. It should be publicly posted, not “available on request.” Second, confirm it includes both HPLC purity data and Mass Spectrometry identity confirmation. HPLC alone tells you purity. MS tells you the compound is actually what the label says. Third, match the lot or batch number on the COA to the batch number on your vial. If they don't match, the COA is decorative. Full guide: How We Verify COAs.

Why does a vendor with a lower total score still get Grade A?

The three core evidence signals (public COA, batch traceability, named lab) are the foundation of verifiable transparency. A vendor that confirms all three earns Grade A regardless of total score, because those signals let you independently verify claims before purchase. Skye Peptides scores 3.0 total but earns an A because every core signal checks out.

What are the biggest red flags when evaluating a peptide vendor?

No publicly posted COA. No named third-party lab on the COA. No batch or lot number on COAs or vials. BPC-157 priced under $15/5mg (legitimate range: $35–75 in 2026). Cryptocurrency as the only payment option. Perfect 99.9% purity claims with no documentation. Medical or dosing claims on product pages. Anonymous ownership with no business entity. Website younger than 6 months with no verifiable history. Any single red flag warrants caution. Multiple flags together mean look elsewhere.